Want to join the conversation?
$LH 2Q15 Call: We expect LabCorp Diagnostics to grow 3.5-5.5% in 2015, after the impact of approx. 70BP of negative currency. This is an increase from our prior guidance of 3-5%. We expect change in Covance drug development net revenue to be in range of minus 1.5 to plus 0.5% vs. full year 2014, after impact of approx. 320BP of negative currency.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?